Journals / Okmeydanı Tıp Dergisi / 2013 / Cilt: 29 - Sayı: 1

The usage of ıntrauterine device and tubo-ovarian abscess

Rahim içi araç kullanımı ve tubo-ovaryen apse

Pages
22–25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: There is a significant statistical diffe- rence between TOA and medical therapy group on this study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to investigate the relationship of intrauterine device usage and the duration of intrauterine device usage with the formation of tubo-ovarian abscess.
📊
Key Findings & Data:Material and Methods: The reports of patients who were treated in our clinic with the diagnosis of pelvic inflammatory disease, between january 2006 and de- cember 2010, were analyzed. 60 patients who were treated medically and 58 patients who were opera- ted on for a tubo-ovarian abscess were compared in terms of intrauterine device usage, duration of usage and laboratory and clinical findings.
💡
Conclusion & Impact:Conclusion: There is a significant statistical diffe- rence between TOA and medical therapy group on this study.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to investigate the relationship of intrauterine device usage and the duration of intrauterine device usage with the formation of tubo-ovarian abscess. Material and Methods: The reports of patients who were treated in our clinic with the diagnosis of pelvic inflammatory disease, between january 2006 and de- cember 2010, were analyzed. 60 patients who were treated medically and 58 patients who were opera- ted on for a tubo-ovarian abscess were compared in terms of intrauterine device usage, duration of usage and laboratory and clinical findings. Results: In the group of patients who were treated medically with diagnosis of pelvic inflammatory di- sease, 9 patients were using intrauterin device; and in the group of patients operated for tubo-ovarian abscess, 30 patients were intrauterin device users. The duration of the intrauterine device usage was approximately 7.3 years in the group treated medi- cally and 8.04 years in the group operated. Conclusion: There is a significant statistical diffe- rence between TOA and medical therapy group on this study.

Özet

Amaç: Bu çalışmanın amacı rahim içi araç kullanımı ve kullanım süresinin uzunluğunun tubo-ovaryan abse gelişimi ile olan ilişkisini incelemektir. Gereç ve Yöntemler: Okmeydanı Eğitim ve Araş- tırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği’nde 0cak 2006-Aralık 2010 tarihleri arasın- da pelvik enflamatuar hastalık tanısı alan ve tedavi edilen 118 hasta; medikal tedavi edilen 60 hasta ile tubo-ovaryan abse nedeniyle opere edilen 58 has- ta, rahim içi araç kullanımı ve süresi ile klinik ve labaratuar bulguları açısından retrospektif olarak çalışmaya alındı. Bulgular: Medikal tedavi edilen pelvik inflamatuar hastalık grubunda 9 hasta (% 15) rahim içi araç kul- lanmaktayken, tubo-ovaryan abse nedeniyle opere edilen grupta 30 hasta (% 51.7) rahim içi araç kul- lanmaktaydı. Medikal tedavi edilen grupta rahim içi araç kullanım süresi ortalama 7.3 yıl opere edi- len grupta ise rahim içi araç kullanım süresi ortala- ma 8.04 yıl idi. Sonuç: Çalışma TOA ve medikal tedavi grupları ara- sında RİA kullanımı açısından istatiksel olarak an- lamlı bir fark olduğunu ortaya koymuştur.

🔖

Cite This Article

TAHAOĞLU, A. E., MİHMANLI, V., ÇETİNKAYA, N., GÜZEL, Y., MİRZA, T., TOPRAKÇI, G., PUL, S. (2013). The usage of ıntrauterine device and tubo-ovarian abscess. Okmeydanı Tıp Dergisi, Cilt: 29 - Sayı: 1, 22–25. https://ajindex.com/articles/291872

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Susan M. Pelvic inflammatory disease and tubo- ovarian abscess. Infect Dis Clin N Am 2008; (22):693- 708
  2. Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease: trends and projecti- ons. JAMA 1991; (266):2565-9. http://dx.doi.org/10.1001/jama.1991.03470180065039 PMid:1942401 3. Quan M. Pelvic inflamamatory disease: diagnosis and management. J Am Board Fam Pract 1994; (7):110-23. PMid:8184701 4. Beigi RH, Wiesenfeld HC. Pelvic inflammatory disease: new diagnostic criteria and treatment. Obstet Gyne- col Clin North Am 2003; (30):777-93.
  3. Sweet RL. Pelvic inflammatory disease. İnfectious di- seases of the famale genital tract. 4th edition. Phile- delphia: lipincott&Williams Wilkins; 2001, 368-412
  4. Jossens MO, Eskenazi B, Schachter J, et al. Risk factors for pelvic inflammatory disease:a case control study. Sex Transm Dis 1996; (23):239-47. http://dx.doi.org/10.1097/00007435-199605000-00014 PMid:8724516 7. Centers for Disease Control and Prevention. Sexu- ally transmitted diseases treatment guidelines 2006. MMWR Recomm Rep 2006; (55):1-77
  5. Lee NC, Rubin GL, Borucki R. The intrauterine devi- ce and pelvic inflammatory disease. Lancet 1992; (340):248-49
  6. Karakulak M, Pala HG, Aydı Y, Saatli B, Güçlü S. Tu- bovaryan abseli olguların değerlendirilmesi. DEÜ Tıp Fakültesi Dergisi 2008; 22(1):9-13
  7. Kuru O, Şen S, Saygılı H, Berkman S. Tubo-ovarian abse: konservatif tedavi başarısızlığındaki risk fak- törleri. Türk Jinekoloji ve Obstetrik Dergisi 2012; 9(2):106-109
  8. Turan V, Ergenoğlu M, Yeniel Ö, ve ark. Kliniğimizde tubo-ovarian abselerin beş yıllık değerlendirilmesi. Türkiye Klinikleri Jinekoloji ve Obstetrik Dergisi 2009; 19(6):349-353
  9. Farley TM, Rosenberg MJ, Rowe PJ, Chen JH, Meirik O. Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 1992; 339:785- 88.
  10. Beerthuizen RJ. Pelvic inflammatory disease in intra- uterine device users. Eur J Contracept Reprod Health Care 1996; (1):237-43. http://dx.doi.org/10.3109/13625189609150665 PMid:9678122 14. Tanır HM, Hassa H, Özalp S,Kaya M, Öge T. Pelvic abs- cess in intrauterine device users. T Europan J Contr and Repr Healt Care 2005; 10(1):15-18. http://dx.doi.org/10.1080/13625180400020820 PMid:16036293 15. Dehal SA, Kaplan MA, Brown R. Clinically inapparent tuboovarian actinimycosis in a woman with an IUD: A case report. J Reprod